U2Bio Co., Ltd. (KOSDAQ:221800)
19,490
-910 (-4.46%)
At close: Apr 28, 2026
U2Bio Revenue
In the year 2025, U2Bio had annual revenue of 25.59B KRW with 2.21% growth. U2Bio had revenue of 6.27B in the quarter ending December 31, 2025, with 0.11% growth.
Revenue
25.59B
Revenue Growth
+2.21%
P/S Ratio
12.13
Revenue / Employee
n/a
Employees
n/a
Market Cap
310.52B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MNtech | 538.53B |
| Lumir | 10.57B |
| NAU Robotics Co.,Ltd | 12.53B |
| Huons | 620.77B |
| MEGAELECTRONICS | 96.49B |
| KNJ Co., Ltd. | 84.44B |
| COOCON | 73.02B |
| Saltlux | 41.64B |